- Home
- WIMI vs IGC Comparison
WIMI vs IGC Comparison
Compare WIMI & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- IGC
- Stock Information
- Founded
- WIMI 2015
- IGC 2005
- Country
- WIMI China
- IGC United States
- Employees
- WIMI N/A
- IGC N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- IGC Health Care
- Exchange
- WIMI Nasdaq
- IGC Nasdaq
- Market Cap
- WIMI 38.3M
- IGC 33.8M
- IPO Year
- WIMI 2020
- IGC N/A
- Fundamental
- Price
- WIMI $3.02
- IGC $0.32
- Analyst Decision
- WIMI
- IGC Strong Buy
- Analyst Count
- WIMI 0
- IGC 2
- Target Price
- WIMI N/A
- IGC $4.00
- AVG Volume (30 Days)
- WIMI 96.9K
- IGC 626.1K
- Earning Date
- WIMI 01-01-0001
- IGC 11-17-2025
- Dividend Yield
- WIMI N/A
- IGC N/A
- EPS Growth
- WIMI N/A
- IGC N/A
- EPS
- WIMI 1.43
- IGC N/A
- Revenue
- WIMI $61,329,146.00
- IGC $1,106,000.00
- Revenue This Year
- WIMI N/A
- IGC $3.54
- Revenue Next Year
- WIMI N/A
- IGC $15.12
- P/E Ratio
- WIMI $2.03
- IGC N/A
- Revenue Growth
- WIMI N/A
- IGC N/A
- 52 Week Low
- WIMI $2.24
- IGC $0.25
- 52 Week High
- WIMI $9.66
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- WIMI 41.05
- IGC 30.14
- Support Level
- WIMI $2.67
- IGC $0.31
- Resistance Level
- WIMI $3.13
- IGC $0.34
- Average True Range (ATR)
- WIMI 0.18
- IGC 0.02
- MACD
- WIMI 0.03
- IGC -0.00
- Stochastic Oscillator
- WIMI 55.51
- IGC 10.73
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.